Literature DB >> 8172902

The glutamate racemase activity from Escherichia coli is regulated by peptidoglycan precursor UDP-N-acetylmuramoyl-L-alanine.

P Doublet1, J van Heijenoort, D Mengin-Lecreulx.   

Abstract

The murI gene product of Escherichia coli was recently identified as the glutamate racemase activity which catalyzes the formation of D-glutamic acid, one of the essential components of bacterial cell-wall peptidoglycan [Doublet et al. (1993) J. Bacteriol. 175, 2970-2979]. We here describe the purification to homogeneity and the kinetic properties of this enzyme. In vitro, the glutamate racemase activity shows an absolute requirement for UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala), the substrate of the D-glutamic acid-adding enzyme which catalyzes the subsequent step in the pathway for peptidoglycan synthesis. The affinity of the enzyme for this activator is particularly high (KD = 4 microM) and specific, since no other peptidoglycan precursor from UDP-GlcNAc to UDP-MurNAc-pentapeptide is an effector. Minor chemical modifications of the UDP-MurNAc-L-Ala molecule, such as the reduction of the uracyl moiety, suppress its activating effect. This specific in vitro requirement most likely represents the physiological mechanism which regulates the activity of the glutamate racemase in vivo. It adjusts the formation of D-glutamic acid to the requirements of peptidoglycan synthesis and avoids an excessive racemization of the intracellular pool of L-glutamic acid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172902     DOI: 10.1021/bi00183a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Comparison of the D-glutamate-adding enzymes from selected gram-positive and gram-negative bacteria.

Authors:  A W Walsh; P J Falk; J Thanassi; L Discotto; M J Pucci; H T Ho
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Nature of allosteric inhibition in glutamate racemase: discovery and characterization of a cryptic inhibitory pocket using atomistic MD simulations and pKa calculations.

Authors:  Katie L Whalen; Kenneth B Tussey; Steven R Blanke; M Ashley Spies
Journal:  J Phys Chem B       Date:  2011-03-11       Impact factor: 2.991

3.  Functional comparison of the two Bacillus anthracis glutamate racemases.

Authors:  Dylan Dodd; Joseph G Reese; Craig R Louer; Jimmy D Ballard; M Ashley Spies; Steven R Blanke
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

4.  Bacterial glutamate racemase has high sequence similarity with myoglobins and forms an equimolar inactive complex with hemin.

Authors:  S Y Choi; N Esaki; M Ashiuchi; T Yoshimura; K Soda
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase.

Authors:  M J Pucci; J A Thanassi; H T Ho; P J Falk; T J Dougherty
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

6.  Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design.

Authors:  Melissa May; Shahila Mehboob; Debbie C Mulhearn; Zhiqiang Wang; Huidong Yu; Gregory R J Thatcher; Bernard D Santarsiero; Michael E Johnson; Andrew D Mesecar
Journal:  J Mol Biol       Date:  2007-06-04       Impact factor: 5.469

Review 7.  Glutamate racemase as a target for drug discovery.

Authors:  Stewart L Fisher
Journal:  Microb Biotechnol       Date:  2008-05-11       Impact factor: 5.813

8.  AMIN domains have a predicted role in localization of diverse periplasmic protein complexes.

Authors:  Robson Francisco de Souza; Vivek Anantharaman; Sandro José de Souza; L Aravind; Frederico J Gueiros-Filho
Journal:  Bioinformatics       Date:  2008-08-21       Impact factor: 6.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.